Rossmore Private Capital Gilead Sciences, Inc. Transaction History

Rossmore Private Capital

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$71.58 - $87.29 $7,158 - $8,729	-100 Reduced 1.73%	5,686 $416,000
Q4 2023 Feb 07, 2024	BUY	$73.27 - $83.09 $1,831 - $2,077	25 Added 0.43%	5,786 $468,000
Q3 2023 Nov 13, 2023	SELL	$73.94 - $80.67 $22,182 - $24,201	-300 Reduced 4.95%	5,761 $431,000
Q2 2023 Aug 11, 2023	SELL	$76.01 - $86.7 $152,020 - $173,400	-2,000 Reduced 24.81%	6,061 $467,000
Q4 2022 Feb 13, 2023	BUY	$62.32 - $89.47 $20,690 - $29,704	332 Added 4.3%	8,061 $692,000
Q2 2022 Aug 11, 2022	BUY	$57.72 - $65.01 $23,088 - $26,004	400 Added 5.46%	7,729 $478,000
Q1 2022 May 09, 2022	SELL	$57.92 - $72.58 $20,272 - $25,403	-350 Reduced 4.56%	7,329 $436,000
Q3 2021 Nov 08, 2021	SELL	$67.69 - $73.03 $67,690 - $73,030	-1,000 Reduced 11.52%	7,679 $536,000
Q1 2021 May 10, 2021	BUY	$60.0 - $68.46 $57,300 - $65,379	955 Added 12.36%	8,679 $561,000
Q4 2020 Feb 10, 2021	BUY	$56.65 - $64.55 $184,792 - $210,562	3,262 Added 73.11%	7,724 $450,000
Q3 2020 Nov 10, 2020	BUY	$62.1 - $78.08 $1,614 - $2,030	26 Added 0.59%	4,462 $282,000
Q2 2020 Aug 05, 2020	BUY	$72.34 - $84.0 $320,900 - $372,624	4,436 New	4,436 $341,000
Q1 2018 May 04, 2018	SELL	$72.84 - $88.8 $65,556 - $79,920	-900 Closed	0 $0
Q4 2017 Mar 15, 2018	BUY	$71.15 - $83.52 $64,035 - $75,168	900	900 $64.5 Million

1,931

991M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Rossmore Private Capital, based on Form 13F filings with the SEC.

Stay updated on Rossmore Private Capital with notifications on news.